Package 67457-994-05

{"route": ["INTRAVENOUS"], "spl_id": "e6bccf18-bc12-4f68-a021-af21b5026e16", "openfda": {"nui": ["N0000178375", "N0000175788"], "upc": ["0367457994055"], "unii": ["2XLN4Y044H"], "spl_set_id": ["e1ab38bf-cfd0-444f-a8a6-bb8588b63228"], "pharm_class_epc": ["Adenosine Receptor Agonist [EPC]"], "pharm_class_moa": ["Adenosine Receptor Agonists [MoA]"], "manufacturer_name": ["Mylan Institutional LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 SYRINGE in 1 CARTON (67457-994-05)  / 5 mL in 1 SYRINGE", "package_ndc": "67457-994-05", "marketing_end_date": "20260630", "marketing_start_date": "20230921"}], "brand_name": "Regadenoson", "product_id": "67457-994_e6bccf18-bc12-4f68-a021-af21b5026e16", "dosage_form": "INJECTION", "pharm_class": ["Adenosine Receptor Agonists [MoA]", "Pharmacologic Cardiac Stress Test Agent [EPC]"], "product_ndc": "67457-994", "generic_name": "Regadenoson", "labeler_name": "Mylan Institutional LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Regadenoson", "active_ingredients": [{"name": "REGADENOSON", "strength": ".4 mg/5mL"}], "application_number": "ANDA213856", "marketing_category": "ANDA", "marketing_end_date": "20260630", "marketing_start_date": "20230921"}